2021
DOI: 10.1109/tnsre.2021.3113636
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of Spinal Cord Stimulation Using Bayesian Preference Learning and Its Validation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
25
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 21 publications
(25 citation statements)
references
References 18 publications
0
25
0
Order By: Relevance
“…Every month, a preference model was created based on daily preference evaluations with preference predictions also for untested parameters and new settings, with promising results. 46 These results on pilot data do not apply to selecting patients suitable for SCS, but on selecting patients for specific stimulation paradigms. As widely acknowledged in this field and despite the inclusion of a temporary SCS-screening trial before IPG implantation, the initial effectiveness of SCS generally declines over time, due to growing tolerance of the central nervous system, 47 which eventually causes loss of efficacy.…”
Section: Outcome-based Patient Selectionmentioning
confidence: 99%
See 1 more Smart Citation
“…Every month, a preference model was created based on daily preference evaluations with preference predictions also for untested parameters and new settings, with promising results. 46 These results on pilot data do not apply to selecting patients suitable for SCS, but on selecting patients for specific stimulation paradigms. As widely acknowledged in this field and despite the inclusion of a temporary SCS-screening trial before IPG implantation, the initial effectiveness of SCS generally declines over time, due to growing tolerance of the central nervous system, 47 which eventually causes loss of efficacy.…”
Section: Outcome-based Patient Selectionmentioning
confidence: 99%
“…Instead of focusing only on whether SCS will be effective in the long term, a recent study explored the value of a Bayesian preference-optimization algorithm to assist clinicians in the systematic programming of individualized therapeutic stimulation, based on expressed preferences for stimulation settings. 46 The main focus was on optimization of temporal stimulation parameters, namely pulse frequency and pulse width, in combination with optimal spatial configuration, which was determined by clinician tuning and electromyograph measurements. Every month, a preference model was created based on daily preference evaluations with preference predictions also for untested parameters and new settings, with promising results.…”
Section: Outcome-based Patient Selectionmentioning
confidence: 99%
“…On the third and fourth days, optimal single-site stimulation parameters (frequency, pulse width, and amplitude) were identified separately for the prior contact choices based on the result of a Bayesian parameter space optimization utilizing a probit Gaussian process to assess her preferences, similar to what we have previously described in Zhao et al [ 7 ]. Four initial settings were chosen, from the combination of two frequencies (50 and 20 Hz for M1 and 26 and 50 Hz for dlPFC) and two pulse widths (150 and 60 μs for M1 and 150 and 300 μs for dlPFC).…”
Section: Case Presentationmentioning
confidence: 99%
“…Since many of these reports were published, advancements in neuromodulation and its underlying technology have fueled innovation in novel targets, personalization, and closing the loop between electrophysiology and neurostimulation [ 4 , 5 , 6 ]. Recently, we have developed and tested a novel Bayesian optimization platform for objectively determining neurostimulation parameters based on patient feedback with forced binary choice [ 7 ]. This approach facilitates a methodology for continuous optimization that we hypothesized could aid with finding optimal parameters during a trial externalization for CPSP.…”
Section: Introduction/backgroundmentioning
confidence: 99%
“…Despite ongoing optimization, we previously reported that the total sEMG activity of the legs seemed to plateau and even decrease after the first six months despite a subjective improvement in motor control (Pino et al, 2020), (Zhao et al, 2021). As a result, we endeavored to objectively characterize changes in neuromuscular control over time with SCS therapy associated with spinal cord plasticity to better elucidate this discrepancy.…”
Section: Introductionmentioning
confidence: 99%